194 related articles for article (PubMed ID: 7214749)
1. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
Kiilerich S; Christiansen C; Christensen MS; Naestoft J
Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
3. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
Vattimo A
Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
Binswanger U; Schiffl H; Huggler M; Becker C
Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
[TBL] [Abstract][Full Text] [Related]
7. Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in man.
Thomsen K; Riis BJ; Hummer L; Christiansen C
Acta Vitaminol Enzymol; 1985; 7(3-4):167-71. PubMed ID: 3879105
[TBL] [Abstract][Full Text] [Related]
8. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
9. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
Christiansen C; Rødbro P; Christensen MS; Hartnack B; Transbøl I
Lancet; 1978 Sep; 2(8092 Pt 1):700-3. PubMed ID: 80633
[TBL] [Abstract][Full Text] [Related]
10. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
[TBL] [Abstract][Full Text] [Related]
11. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
[TBL] [Abstract][Full Text] [Related]
12. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
Schulz W; Spiegel P; Gessler U; Delling G
Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
[No Abstract] [Full Text] [Related]
13. [Clinical importance of disorders of vitamin D metabolism].
Flury W
Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
[TBL] [Abstract][Full Text] [Related]
14. Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
Kanis JA; Cundy T; Bartlett M; Smith R; Heynen G; Warner GT; Russell RG
Br Med J; 1978 May; 1(6124):1382-6. PubMed ID: 647302
[TBL] [Abstract][Full Text] [Related]
15. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
[No Abstract] [Full Text] [Related]
16. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis.
Blumberg A; Wildbolz A; Descoeudres C; Hennes U; Dambacher MA; Fischer JA; Weidmann P
Clin Nephrol; 1980 May; 13(5):208-14. PubMed ID: 6772366
[TBL] [Abstract][Full Text] [Related]
17. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man.
Muirhead N; Catto GR; Gvozdanovic S; Gvozdanovic D; Edward N
Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197
[TBL] [Abstract][Full Text] [Related]
18. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
Chan JC; Oldham SB; Holick MF; DeLuca HF
JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
[TBL] [Abstract][Full Text] [Related]
19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
